Chelatexx (Reformulated Orlistat) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Chelatexx (Reformulated Orlistat) General Information

Description

Manufacturer of C-103, a reformulated version of orlistat for weight management. Orlistat is marketed in prescription strength by Roche Laboratories (Xenical(R) 120mg capsules) and in over-the-counter strength by GlaxoSmithKline Consumer Healthcare (alli(R) 60mg capsules). Orlistat is an FDA-approved weight management drug for a pediatric population (adolescents 12 years and older).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 110 Stanbery Ridge
  • Fort Thomas, KY 41075
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chelatexx (Reformulated Orlistat) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chelatexx (Reformulated Orlistat)‘s full profile, request access.

Request a free trial

Chelatexx (Reformulated Orlistat) Executive Team (1)

Name Title Board Seat Contact Info
Gary Thompson President & Chief Executive Officer
To view Chelatexx (Reformulated Orlistat)’s complete executive team members history, request access »